featured
Ramucirumab With Cisplatin and Fluoropyrimidine as First-Line in Metastatic Gastric or Junctional Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ramucirumab With Cisplatin and Fluoropyrimidine as First-Line Therapy in Patients With Metastatic Gastric or Junctional Adenocarcinoma (RAINFALL): A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial
Lancet Oncol 2019 Feb 01;[EPub Ahead of Print], CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, E Van Cutsem, DH Ilson, M Alsina, I Chau, J Lacy, M Ducreux, GA Mendez, AM Alavez, D Takahari, W Mansoor, PC Enzinger, V Gorbounova, ZA Wainberg, S Hegewisch-Becker, D Ferry, J Lin, R Carlesi, M Das, MA ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.